Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
mlHealth 360 is a Canadian healthtech company specializing in AI-powered medical imaging solutions designed to enhance radiologist efficiency and diagnostic accuracy. Founded in 2023 and headquartered in Surrey, British Columbia, the company developed the Scaida platform, an enterprise imaging suite that provides automated triage, diagnostic support, and standardized reporting. Its flagship product, Scaida BrainCT-ICH, received FDA 510(k) clearance in late 2025 for the automated triage of intracranial hemorrhages on non-contrast head CT scans, marking a significant milestone as the first Canadian-developed AI of its kind to be cleared. The company's technology leverages a repository of over 30 million datasets to train advanced machine learning models that cover various anatomical regions, including the head, chest, and spine. mlHealth 360 aims to disrupt the healthcare industry by integrating secure, cloud-native AI into existing clinical workflows to improve patient outcomes globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on mlHealth 360.